MedaPhor Group plc (AIM: MED), the intelligent ultrasound software and simulation company, is pleased to announce that at the General Meeting held earlier today, all resolutions proposed were duly passed by shareholders. Accordingly, the Company has raised £5.08 million in the Placing and Open Offer and has issued and allotted 59,750,331 Placing and Open Offer Shares, conditional only on Admission becoming effective. Admission of the Placing and Open Offer Shares is expected at 8.00 a.m. on 13 December 2018.

Following Admission, the Company’s issued ordinary share capital will comprise 156,627,749 Ordinary Shares, of which none are held in treasury. The above figure of 156,627,749 may be used by Shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the voting rights of the Company under the FCA’s Disclosure Guidance and Transparency Rules.

Unless otherwise defined herein, capitalised terms used in this announcement shall have the same meanings as defined in the circular sent to shareholders of the Company on 26 November 2018.

Enquiries: investors.medaphor.com/advisors